Surrozen, Inc./DE ·
SRZN 8-K 2026-11-16
Surrozen, Inc./DE (SRZN) 8-K dated 2026-11-16 — accession 0001193125-26-462191.
Surrozen, Inc./DE (SRZN) is a biotechnology company listed on US.
Surrozen, Inc./DE filed a 8-K on 2026-11-16. Accession 0001193125-26-462191.
This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SRZN revenue for 2025-12-31 was $3.5M. Net income was -$242.0M. Revenue was down 67.4% from 2024-12-31 to 2025-12-31. SRZN currently screens at market cap $71.6M.
Not investment advice. The SRZN SEC hub lists recent forms. The stock page is the research view.